2019 Cancer Grant

Recipients

previous recipients

Stefanie

Avril

MD

2019

Case Western Reserve University School of Medicine

Targeting CDK5 as a novel immunotherapeutic approach in triple-negative breast cancer

Learn more: https://case.edu/medicine/pathology/faculty/stefanie-avril

Justin

Balko

Ph.D.

2019

Vanderbilt University Medical Center

Cooperative role of JAK2 and PD-L1 in driving 9p24 amplified breast cancer aggressiveness and response

Learn more: https://wag.app.vanderbilt.edu/PublicPage/Faculty/Details/38098

Hani

Goodarzi

Ph.D.

2019

The Regents of the University of California

Leveraging circulating cancer-specific orphan RNAs to detect and monitor cancer

Learn more: http://cancer.ucsf.edu/people/profiles/goodarzi_hani.7686

Wenjun

Guo

Ph.D.

2019

Albert Einstein College of Medicine

Role of the epigenetic regulator MLL3 mutation in breast cancer endocrine resistance

Learn more: http://www.einstein.yu.edu/faculty/13006/wenjun-guo/

Cecil

Han

Ph.D.

2019

Georgetown University

Impact of metabolic reprogramming on ovarian cancer initiation

Learn more: https://gufaculty360.georgetown.edu/s/contact/00336000017GnL4AAK/cecil-han

Jae-Wook

Jeong

Ph.D.

2019

Michigan State University

The role of cholesterol metabolism in recurrent endometrial cancer.

Learn more: https://obgyn.msu.edu/research/research-faculty/jae-wook-jeong-phd

Weibo

Luo

Ph.D.

2019

UT Southwestern Medical Center

Targeting ZMYND8A5:AA9 to improve immunotherapy in breast cancer

Learn more: https://profiles.utsouthwestern.edu/profile/154146/weibo-luo.html

Irina

Matei

Ph.D.

2019

Weill Cornell Medicine

Dissecting the tumor immune microenvironment in immunocompetent models of breast cancer brain metastasis

Minna

Roh-Johnson

Ph.D.

2019

University of Utah

Immune cell contributions to breast cancer cell metabolism during metastasis

Learn more: https://www.bioscience.utah.edu/faculty/rohjohnson/

Priyanka

Sharma

MD

2019

University of Kansas

Evaluation of longitudinal ctDNA to elucidate markers of response and acquired drug resistance to PI3K inhibitor therapy

Learn more: http://www.kumc.edu/school-of-medicine/internal-medicine/clinical-divisions/medical-oncology/faculty/priyanka-sharma-md.html

Lu

Xin

Ph.D.

2019

University of Notre Dame

Novel antibody-drug conjugate as personalized therapy for metastatic breast, ovarian and endometrial Cancers

Learn more: https://biology.nd.edu/people/xin-lu/

previous recipients
homecausesgiveeventsblog
donate now